vs

Side-by-side financial comparison of Ceribell, Inc. (CBLL) and TRIO-TECH INTERNATIONAL (TRT). Click either name above to swap in a different company.

Ceribell, Inc. is the larger business by last-quarter revenue ($24.8M vs $15.6M, roughly 1.6× TRIO-TECH INTERNATIONAL). TRIO-TECH INTERNATIONAL runs the higher net margin — 0.8% vs -54.6%, a 55.4% gap on every dollar of revenue. TRIO-TECH INTERNATIONAL produced more free cash flow last quarter ($-152.0K vs $-11.0M).

Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.

Trio-Tech International is a global provider of semiconductor testing and burn-in solutions, alongside specialized manufacturing services for electronic components. It serves clients across the semiconductor, aerospace, and consumer electronics sectors, with operational footprints spanning North America, Asia, and Europe, delivering custom reliability testing systems and related support services.

CBLL vs TRT — Head-to-Head

Bigger by revenue
CBLL
CBLL
1.6× larger
CBLL
$24.8M
$15.6M
TRT
Higher net margin
TRT
TRT
55.4% more per $
TRT
0.8%
-54.6%
CBLL
More free cash flow
TRT
TRT
$10.8M more FCF
TRT
$-152.0K
$-11.0M
CBLL

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
CBLL
CBLL
TRT
TRT
Revenue
$24.8M
$15.6M
Net Profit
$-13.5M
$126.0K
Gross Margin
87.3%
16.0%
Operating Margin
-58.9%
0.6%
Net Margin
-54.6%
0.8%
Revenue YoY
81.6%
Net Profit YoY
-75.1%
EPS (diluted)
$-0.35
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBLL
CBLL
TRT
TRT
Q4 25
$24.8M
$15.6M
Q3 25
$22.6M
$15.5M
Q2 25
$21.2M
$10.7M
Q1 25
$20.5M
$7.4M
Q4 24
$8.6M
Q3 24
$17.2M
$9.8M
Q2 24
$9.7M
Q1 24
$10.4M
Net Profit
CBLL
CBLL
TRT
TRT
Q4 25
$-13.5M
$126.0K
Q3 25
$-13.5M
$77.0K
Q2 25
$-13.6M
$183.0K
Q1 25
$-12.8M
$-495.0K
Q4 24
$507.0K
Q3 24
$-10.4M
$-236.0K
Q2 24
$243.0K
Q1 24
$70.0K
Gross Margin
CBLL
CBLL
TRT
TRT
Q4 25
87.3%
16.0%
Q3 25
88.3%
16.7%
Q2 25
88.1%
24.6%
Q1 25
87.9%
26.8%
Q4 24
25.7%
Q3 24
87.3%
23.7%
Q2 24
27.5%
Q1 24
26.0%
Operating Margin
CBLL
CBLL
TRT
TRT
Q4 25
-58.9%
0.6%
Q3 25
-64.8%
0.3%
Q2 25
-70.5%
4.4%
Q1 25
-69.3%
-4.6%
Q4 24
-0.0%
Q3 24
-57.8%
1.4%
Q2 24
3.7%
Q1 24
0.6%
Net Margin
CBLL
CBLL
TRT
TRT
Q4 25
-54.6%
0.8%
Q3 25
-59.6%
0.5%
Q2 25
-64.4%
1.7%
Q1 25
-62.4%
-6.7%
Q4 24
5.9%
Q3 24
-60.6%
-2.4%
Q2 24
2.5%
Q1 24
0.7%
EPS (diluted)
CBLL
CBLL
TRT
TRT
Q4 25
$-0.35
$0.01
Q3 25
$-0.37
$0.02
Q2 25
$-0.38
$0.11
Q1 25
$-0.36
$-0.12
Q4 24
$0.06
Q3 24
$-1.85
$-0.06
Q2 24
$0.05
Q1 24
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBLL
CBLL
TRT
TRT
Cash + ST InvestmentsLiquidity on hand
$159.3M
$16.5M
Total DebtLower is stronger
$581.0K
Stockholders' EquityBook value
$155.3M
$33.5M
Total Assets
$195.8M
$45.7M
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBLL
CBLL
TRT
TRT
Q4 25
$159.3M
$16.5M
Q3 25
$168.5M
$17.4M
Q2 25
$177.4M
$16.7M
Q1 25
$182.7M
$17.6M
Q4 24
$16.5M
Q3 24
$14.1M
$15.5M
Q2 24
$16.5M
Q1 24
$17.0M
Total Debt
CBLL
CBLL
TRT
TRT
Q4 25
$581.0K
Q3 25
$622.0K
Q2 25
$684.0K
Q1 25
$729.0K
Q4 24
$782.0K
Q3 24
$923.0K
Q2 24
$874.0K
Q1 24
$984.0K
Stockholders' Equity
CBLL
CBLL
TRT
TRT
Q4 25
$155.3M
$33.5M
Q3 25
$164.1M
$34.1M
Q2 25
$172.2M
$34.0M
Q1 25
$180.9M
$32.3M
Q4 24
$31.8M
Q3 24
$-136.0M
$33.1M
Q2 24
$31.3M
Q1 24
$31.2M
Total Assets
CBLL
CBLL
TRT
TRT
Q4 25
$195.8M
$45.7M
Q3 25
$199.5M
$47.4M
Q2 25
$207.7M
$41.1M
Q1 25
$213.5M
$40.0M
Q4 24
$39.8M
Q3 24
$47.1M
$42.9M
Q2 24
$42.5M
Q1 24
$43.1M
Debt / Equity
CBLL
CBLL
TRT
TRT
Q4 25
0.02×
Q3 25
0.02×
Q2 25
0.02×
Q1 25
0.02×
Q4 24
0.02×
Q3 24
0.03×
Q2 24
0.03×
Q1 24
0.03×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBLL
CBLL
TRT
TRT
Operating Cash FlowLast quarter
$-10.8M
$134.0K
Free Cash FlowOCF − Capex
$-11.0M
$-152.0K
FCF MarginFCF / Revenue
-44.2%
-1.0%
Capex IntensityCapex / Revenue
0.7%
1.8%
Cash ConversionOCF / Net Profit
1.06×
TTM Free Cash FlowTrailing 4 quarters
$-41.6M
$137.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBLL
CBLL
TRT
TRT
Q4 25
$-10.8M
$134.0K
Q3 25
$-11.1M
$933.0K
Q2 25
$-7.5M
$-664.0K
Q1 25
$-11.4M
$781.0K
Q4 24
$2.1M
Q3 24
$-1.9M
Q2 24
$199.0K
Q1 24
$1.2M
Free Cash Flow
CBLL
CBLL
TRT
TRT
Q4 25
$-11.0M
$-152.0K
Q3 25
$-11.5M
$887.0K
Q2 25
$-7.6M
$-1.2M
Q1 25
$-11.6M
$623.0K
Q4 24
$1.9M
Q3 24
$-1.9M
Q2 24
$-135.0K
Q1 24
$1.1M
FCF Margin
CBLL
CBLL
TRT
TRT
Q4 25
-44.2%
-1.0%
Q3 25
-50.8%
5.7%
Q2 25
-35.9%
-11.4%
Q1 25
-56.4%
8.4%
Q4 24
22.4%
Q3 24
-19.7%
Q2 24
-1.4%
Q1 24
10.6%
Capex Intensity
CBLL
CBLL
TRT
TRT
Q4 25
0.7%
1.8%
Q3 25
1.6%
0.3%
Q2 25
0.3%
5.2%
Q1 25
0.7%
2.1%
Q4 24
2.1%
Q3 24
0.7%
Q2 24
3.4%
Q1 24
0.5%
Cash Conversion
CBLL
CBLL
TRT
TRT
Q4 25
1.06×
Q3 25
12.12×
Q2 25
-3.63×
Q1 25
Q4 24
4.16×
Q3 24
Q2 24
0.82×
Q1 24
16.44×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBLL
CBLL

Products$18.8M76%
Subscription$6.0M24%

TRT
TRT

Semiconductor Backend Solutions$12.4M79%
Industrial Electronics$3.3M21%

Related Comparisons